Projects funded by the NCN
Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of selected antiseizure drugs
2021/41/B/NZ7/00328
Keywords:
glycine transporter type 1 seizures epilepsy epileptogenesis antiseizure drugs
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_7: Signal transduction
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 1 084 400 PLN
Project start date (Y-m-d): 2022-02-04
Project end date (Y-m-d): 2025-02-03
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.